Inogen (INGN) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)
Inogen (INGN) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 7.35% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.56% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 14.29% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 10.46% |
| 10 | Inogen | 174.59 Mn | 80.18 Mn | 37.86 Mn | -18.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.04% |
| Dec 31, 2025 | -18.10% |
| Sep 30, 2025 | -19.89% |
| Jun 30, 2025 | -14.57% |
| Mar 31, 2025 | -16.58% |
| Dec 31, 2024 | -11.76% |
| Sep 30, 2024 | -5.91% |
| Jun 30, 2024 | -4.42% |
| Mar 31, 2024 | 7.24% |
| Dec 31, 2023 | 16.29% |
| Sep 30, 2023 | 21.89% |
| Jun 30, 2023 | 21.72% |
| Mar 31, 2023 | 16.81% |
| Dec 31, 2022 | 11.16% |
| Sep 30, 2022 | 9.62% |
| Jun 30, 2022 | 18.77% |
| Mar 31, 2022 | 26.65% |
| Dec 31, 2021 | 37.89% |
| Sep 30, 2021 | 46.39% |
| Mar 31, 2021 | 57.89% |